APPH logo

Apontis Pharma AG Stock Price

XTRA:APPH Community·€89.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

APPH Share Price Performance

€10.75
0.97 (9.92%)
€10.75
0.97 (9.92%)
Price €10.75

APPH Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
3 Rewards

Apontis Pharma AG Key Details

€51.8m

Revenue

€21.7m

Cost of Revenue

€30.1m

Gross Profit

€29.5m

Other Expenses

€654.5k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.079
58.16%
1.26%
0%
View Full Analysis

About APPH

Founded
1946
Employees
137
CEO
n/a
WebsiteView website
apontis-pharma.de

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Recent APPH News & Updates

Recent updates

No updates